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Background: Patients with dementia have increased healthcare utilization and often have comorbid chronic
conditions. It is not clear if the increase in utilization is driven by dementia, the comorbidities or both. The objective
of this study was to describe the number and types of comorbid conditions in a population-based cohort of older
adults with dementia and how the level of comorbidity impacts dementia-related and non-dementia-related health
service utilization.
Methods: This study is a retrospective cohort study using multiple linked administrative databases to examine
health service utilization and costs of 100,630 community-living older adults living with pre-existing dementia in
Ontario, Canada. Comorbid conditions and health service utilization were measured using administrative data
(physician visits, emergency department visits, hospitalizations, and homecare contacts).
Results: Nearly all, 96.3 %, had at least one comorbid condition, while 18.4 % had five or more comorbid conditions.
The most common comorbid conditions were hypertension (77.8 %), and arthritis (66.2 %). All types of utilization
increased consistently with the number of comorbid conditions. The average number of dementia-related services
tended to be similar across all levels of comorbidity while the average number of non-dementia related visits tended
to increase with the level of comorbidity.
Conclusions: Comorbidities in community-living older adults with dementia are common and account for a
substantial proportion of health service use and costs in this population. Our results suggest that comprehensive
programs that take a holistic view to identify the needs of patients in the context of other comorbidities are required
for persons with dementia living in the community.
Keywords: Dementia, Community-living older adults, Health service utilization, Health service costs, Comorbidity* Correspondence: griffith@mcmaster.ca
1Department of Clinical Epidemiology and Biostatistics, McMaster University,
McMaster Innovation Park, 175 Longwood Road South, Hamilton, ON L8P
0A1, Canada
Full list of author information is available at the end of the article
© The Author(s). 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Griffith et al. BMC Geriatrics  (2016) 16:177 Page 2 of 10Background
Worldwide there are an estimated 47.5 million people
with dementia, and in 2010, the total healthcare cost for
this population was more than 1 % of the global gross
domestic product [1, 2]. In 2011, almost 750,000 Canadians
were living with dementia, with Alzheimer’s disease being
the most common form. [3] Alzheimer’s disease is also
among the top ten diseases contributing to deaths and
years of life lost in the United States [4]. People diagnosed
with dementia tend to have higher health service use, in-
cluding physician visits and hospitalizations, than those not
diagnosed with dementia [5–7]. About half of people with
dementia live in the community [8], and the number is in-
creasing [9]. In this group there is a great reliance on infor-
mal care, in which family and friends are called upon to
provide the majority of care [10]. This is often supported by
home-care and community-based care services to provide
effective continuing care for those people living in the
community with dementia. With the demographic shift
toward older populations, the number of people with
dementia is projected to increase dramatically over the
next 25 years which will impact both formal and informal
care needs [11].
Older adults are also at increased risk for many other
chronic conditions. Multi-morbidity has been increasingly
recognized as an independent risk factor for decreased
quality of life [12], increased disability [13] and premature
mortality [14]. In people with dementia, comorbid con-
ditions can accelerate cognitive [15] and functional [16]
decline. As well, medications or treatments for other
conditions may affect cognitive decline [17] especially
when polypharmacy is associated with multimorbidity
[18]. Thus one may expect dementia-related health ser-
vice use to increase with comorbidity. Dementia may
also complicate clinical care for other chronic conditions
and negatively influence the quality of care received [19].
For example, dementia may impair one’s awareness of
symptoms, capacity for self-management, and ability to
engage in health maintenance activities for other chronic
conditions [20]. Thus in patients with dementia and co-
morbidity, one could speculate that non-dementia-related
health service use may also increase. Although health
service use is not a sufficient proxy for need [21], it
does reflect burden to the healthcare system. From a
health services and policy perspective, research suggests
that multi-morbidity be considered in the allocation of
healthcare resources because estimates of future use of
healthcare services are not well summarized by simply to-
taling the use of services by individual illnesses [22].
Although there are a number of studies describing co-
morbidity [15, 19, 23, 24] and increased health service
utilization and costs [7, 25–28] in people with dementia,
there are only a few population-based studies character-
izing both comorbidity and health service utilization incommunity-living people with dementia, and none to
our knowledge explore if the increase in utilization is
driven by dementia, the comorbidities or both. The ob-
jectives of this study are to: 1) describe the number and
types of comorbid conditions in a population-based co-
hort of older adults with dementia; 2) examine how the
level of comorbidity impacts both dementia-related and
non-dementia-related health service utilization and costs
over a 5-year period.
Methods
Study design
This is a retrospective cohort study using multiple linked
administrative databases to examine health service
utilization and costs of a population-based cohort of
community-living older adults with dementia.
Setting
This study is set in Canada’s most populous province,
Ontario, with approximately 13 million residents. The
vast majority of Ontarians are covered under the provin-
cial health insurance plan (OHIP). Coverage includes
outpatient physician visits, acute care hospital use (both
in the emergency department and inpatient admissions),
homecare, and outpatient prescription drug coverage for
those 65 years and older. In Ontario, Community Care
Access Centres provide publicly funded homecare, using
a contractual model of service delivery, wherein publicly
funded case managers contract out homecare services to
community agencies that provide care to clients.
Data
The administrative databases linked in this study in-
clude: the Registered Persons Database (RPDB) for basic
demographic data on all individuals enrolled in the pro-
vincial insurance program; the OHIP claims database for
physician visits; the Discharge Abstract Database (DAD)
for all records of inpatient hospitalizations; the National
Ambulatory Care Reporting System (NACRS) for all re-
cords of emergency department visits and other ambula-
tory contacts; the Same Day Surgery (SDS) database for
same-day surgeries and procedures, the Home Care
Database (HCD) for information on all homecare service
records; and the Ontario Drug Benefits (ODB) claims
database for all outpatient prescription claims. Additional
data sources were accessed to obtain specific diagnostic
information. These included the Ontario Mental Health
Reporting System (OMHRS), the Ontario Cancer Registry
(OCR), and the Ontario Diabetes Database (ODD). The
data were linked using unique, encoded identifiers and an-
alyzed at the Institute for Clinical Evaluative Sciences
(ICES) in Toronto, Ontario. These data are regularly used
for research purposes and have been studied extensively
for their validity [29–34].
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The cohort consists of all individuals aged 66 and over,
who resided in the community, and had an existing diag-
nosis of dementia as of April 1, 2008 (baseline). We set
our lower age limit at age 66 to have at least 1 year of
available prescription claims, which was necessary to
identify some chronic conditions. We defined dementia
as the presence of at least 1 diagnostic code in the OHIP
claims within the 5 years prior to baseline, or one Inter-
national Classification of Disease (either version 9 or 10
depending on year) in DAD or NACRS within the 5 years
prior to baseline, or 1 claim in the ODB for a cholinester-
ase inhibitor in the year prior to baseline. This definition
of dementia has been used in other population-based
studies that have used administrative databases [35]
(Additional file 1). We required that any relevant claims or
codes be identified prior to October 2007 to ensure
that individuals had the condition for at least 6 months
at baseline, which was part of our definition of a
chronic condition [36]. Individuals who were 105 years
or older, receiving palliative care (in any setting), resid-
ing outside of Ontario, or had no contact with the
health system in the 5 years prior to the baseline date
were excluded. We also excluded individuals residing in
long-term care homes since they tend to have different
patterns of health service utilization than community-
living older adults. From baseline, each individual was
followed until the first of: admission into a long-term
care home, death, a move out of province, or the end of
the 5-year follow-up period.
Comorbid conditions
The comorbid chronic conditions identified were: anxiety/
depression, arthritis, cancer, chronic obstructive pul-
monary disease (COPD), diabetes, upper gastrointes-
tinal bleed, hypertension, ischemic heart disease, liver
disease, osteoporosis/osteopenia, inflammatory bowel
disease, renal disease (with and without chronic dialy-
sis), stroke, and other cerebrovascular disease. The list
was chosen to utilize pre-existing validated ICES dis-
ease algorithms and registries. Each condition was de-
fined using either of the following methods: 1) a
search for diagnostic codes in any of the OHIP, DAD,
or NACRS databases and/or specification prescription
claims within the 5 years prior to baseline; or 2) entry
into a diagnosis-specific database created at ICES
(Additional file 1). Comorbidity status was character-
ized by the number of comorbid conditions at baseline
(0, 1, 2, or 3 or more).
Health services utilization
We identified all publically-funded health services
utilization during the study period. This included
physician visits (both primary care and specialist),unplanned emergency department visits, hospitalizations,
and homecare contacts. We identified hospitalization
“episodes” so that transfers between hospitals were not
counted as separate events. For each hospitalization
episode, we estimated the total length of stay (number
of days from admission to final discharge), the total
number of days in the intensive care unit (ICU), and
total number of days designated as Alternate Level of
Care (ALC). ALC refers to periods of time when a pa-
tient is considered to no longer require hospital-level
care but cannot be discharged due to a lack of alterna-
tive services (for example, when a long-term care bed is
required but not available). This is particularly relevant
in dementia patients since it is the most frequent diag-
nosis associated with ALC designation [37]. We distin-
guished physician visits, emergency department visits,
and hospitalizations for dementia (index condition)
from those for all other reasons (non-index conditions).
For homecare services, we counted the total number of
visits and specific visit types (including case manage-
ment, nursing, in-home support, and therapies) for cost
analyses, but focused on nursing visits for utilization as
they are the most common type of service. We were
unable to distinguish between homecare services for
index and non-index reasons.Statistical methods
We described the cohort at baseline by age, sex, neigh-
bourhood income quintile, and the number and type of
comorbid chronic conditions for the entire cohort, for
those with complete 5-year follow-up, and for those with
less than 5 years of follow-up (most often due to death
or institutionalization). For each year of follow-up, we
estimated the total amount of each type of health service
use (physician services, acute care, and homecare) by
baseline comorbidity status. Costs for each type of health
service were calculated by multiplying the volume of ser-
vice (either total number of visits or hours of service, de-
pending on type) by the published unit cost (cost per visit
or hour, depending on type) (Additional file 2). Total ser-
vice costs for each year in the 5-year follow-up were calcu-
lated by adding the total costs per type. Average annual per
patient costs were estimated by dividing total service costs
by the number of individuals in the cohort at the beginning
of the year. We also estimated the proportion of total health
service costs attributed to physician visits, emergency de-
partment visits, hospitalizations, and homecare. All costs
were expressed in 2012 Canadian (CDN) dollars. Because
the main intent of this study was to present descriptive sta-
tistics on the full population of community-living older
adults with dementia in Ontario, the decision was made
not to use statistical tests given the large cohort size which
would have resulted in small p-values.
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Comorbidity in older adults with dementia
We identified 100,630 community-living older adults with
pre-existing dementia, representing 6 % of the Ontario
population aged 66 years and older, as of April 1, 2008
(Table 1). Approximately 20 % were aged 66–74 years,
48 % were 75–84 years, and 32 % aged 85 or over. WomenTable 1 Baseline characteristics of community-dwelling older adults
Dementia cohort
(n = 100,630)
Age groups (n, %)
66–69 6958 (6.9 %)
70–74 13,421 (13.3 %)
75–79 21,260 (21.1 %)
80–84 26,677 (26.5 %)
85–89 20,833 (20.7 %)
90+ 11,481 (11.4 %)
Female (n, %) 60,964 (60.6 %)
Income quintile (n, %)
1 (Lowest) 21,689 (21.6 %)
2 20,654 (20.5 %)
3 19,273 (19.2 %)
4 18,739 (18.6 %)
5 (Highest) 19,763 (19.6 %)
Number of comorbid conditions (n, %)
0 3750 (3.7 %)
1 13,415 (13.3 %)
2 23,543 (23.4 %)
3 23,923 (23.8 %)
4 17,462 (17.4 %)
5 18,537 (18.4 %)
Comorbid conditions (n, %)
Hypertension 78,246 (77.8 %)
Arthritis 66,601 (66.2 %)
Chronic Obstructive Pulmonary Disease 28,557 (28.4 %)
Diabetes 28,187 (28 %)
Ischemic Heart Disease 24,075 (23.9 %)
Inflammatory Bowel Disease 22,532 (22.4 %)
Cancer 17,981 (17.9 %)
Osteoporosis/osteopenia 10,162 (10.1 %)
Renal Disease 10,153 (10.1 %)
Anxiety and/or Depression 6411 (6.4 %)
Stroke 6294 (6.3 %)
Upper Gastrointestinal Bleed 3862 (3.8 %)
Cerebrovascular Disease 3732 (3.7 %)
Liver Disease 774 (0.8 %)comprised about 60 % of the cohort. The average number
of comorbid conditions was 2.9, which did not vary across
age groups. Nearly all, 96.3 %, had at least 1 comorbid
condition, while 18.4 % had 5 or more comorbid con-
ditions. The most common comorbid conditions were
hypertension (77.8 %), arthritis (66.2 %), COPD (28.4 %)
and diabetes (28.0 %). Over half of the cohort could not bein Ontario living with dementia
Amount of follow-up
5 years (n = 48,458) <5 years (n = 52,172)
5186 (10.7 %) 1772 (3.4 %)
8861 (18.3 %) 4560 (8.7 %)
11,755 (24.3 %) 9505 (18.2 %)
12,252 (25.3 %) 14,425 (27.6 %)
7374 (15.2 %) 13,459 (25.8 %)
3030 (6.3 %) 8451 (16.2 %)
29,357 (60.6 %) 31,607 (60.6 %)
10,027 (20.7 %) 11,662 (22.4 %)
9987 (20.6 %) 10,667 (20.4 %)
9148 (18.9 %) 10,125 (19.4 %)
9152 (18.9 %) 9587 (18.4 %)
9958 (20.5 %) 9805 (18.8 %)
1997 (4.1 %) 1753 (3.4 %)
7116 (14.7 %) 6299 (12.1 %)
12,398 (25.6 %) 11,145 (21.4 %)
11,924 (24.6 %) 11,999 (23 %)
8032 (16.6 %) 9430 (18.1 %)
6991 (14.4 %) 11,546 (22.1 %)
36,962 (76.3 %) 41,284 (79.1 %)
32,427 (66.9 %) 34,174 (65.5 %)
12,277 (25.3 %) 16,280 (31.2 %)
13,289 (27.4 %) 14,898 (28.6 %)
10,527 (21.7 %) 13,548 (26.0 %)
9946 (20.5 %) 12,586 (24.1 %)
7616 (15.7 %) 10,365 (19.9 %)
3449 (7.1 %) 6713 (12.9 %)
3799 (7.8 %) 6354 (12.2 %)
2723 (5.6 %) 3688 (7.1 %)
2524 (5.2 %) 3770 (7.2 %)
1454 (3.0 %) 2408 (4.6 %)
1476 (3.0 %) 2256 (4.3 %)
301 (0.6 %) 473 (0.9 %)
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or institutionalization (16.0 %) during that time. People
followed for the full 5 years tended to be younger and have
fewer chronic conditions (Table 1).
Health service utilization and costs
Figure 1a-e displays the average annual number of phys-
ician visits (a:primary care and b:specialist), c:emergency
department visits, d:hospitalizations, and e:homecare visits
by the number of comorbid conditions for 2008 and 2012.
For all services except homecare visits, dementia-related
and non-dementia-related use is shown. All types of
utilization increased with the number of comorbid condi-
tions. In most cases the 3+ comorbid conditions group
had at least twice the utilization compared to those with
no comorbidities. At all levels of comorbidity the vast ma-
jority of services were attributed to non-dementia reasons.b d
e
Fig. 1 a Average annual number of dementia-related and non-dementia-re
dementia-related and non-dementia-related specialist visits. c Average ann
department visits. d Average annual number of dementia-related and no
dementia-related and non-dementia-related homecare nursing visits by
represent dementia-related utilization and grey bars represent non-demThe average number of dementia-related services tended
to be similar across all levels of comorbidity while the
average number of non-dementia related visits tended to
increase with the level of comorbidity. For all types of ser-
vices, there was little change over the 5 years of follow-up,
except for a slight decrease in the average annual number
of services in those with three or more comorbidities.
There was a similar trend of increasing hospital length
of stay (LOS) for medical and surgical episodes (Fig. 2a)
and for ALC episodes (Fig. 2b) with number of comor-
bidities for non-dementia-related use. Dementia-related
LOS tended to be shorter with increasing level of comor-
bidity. In 2008, the average LOS for acute care episodes
for non-dementia reasons increased with the number of
comorbidities (2.77 days in those with 0 comorbidities to
6.21 days in those with 3+ comorbidities). The average
LOS for acute care episodes associated with dementia waslated General practitioner visits. b Average annual number of
ual number of dementia-related and non-dementia-related emergency
n-dementia-related hospitalizations. e Average annual number of
the number of comorbid conditions in 2008 and 2012. Black bars
entia-related utilization
bFig. 2 a Average length of stay (LOS) for dementia-related and
non-dementia-related medical or surgical hospital episodes by the
number of comorbid conditions in 2008 and 2012. b Average length
of stay (LOS) for dementia-related and non-dementia-related alternate
level of care (ALC) hospital episodes by the number of comorbid
conditions in 2008 and 2012. Black bars represent dementia-related
LOS and grey bars represent non-dementia-related LOS
Fig. 3 Total health services costs in 2008 and 2012 (expressed in 2012 CDN
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for those with one or more comorbidities (0.74 for 1, 0.59
for 2 and 0.67 for 3+). Overall the average LOS decreased
over time for both dementia and non-dementia related ep-
isodes and for all levels of comorbidity.
Figure 3 displays the total costs associated with health
service use in 2008 and 2012 (expressed in 2012 CDN
dollars) by level of comorbidity and by service type.
Total health services costs in 2008 increased sharply with
the number of comorbid conditions from $13,000,000 in
those with 0 to $532,000,000 in those with 3 or more co-
morbid conditions. Among those with 0 comorbid condi-
tions, the main cost driver was homecare but this was
replaced by acute care episodes among those with three or
more conditions. Overall cohort costs declined by 2012
(due to attrition) but the general trends in terms of the
relative drivers of costs at different levels of comorbidity
persisted.
The average annual per patient costs increased with
the number of comorbid conditions from $3467 in those
with 0, to $8873 in those with three or more in 2008
(Fig. 4). Overall average per patients costs, adjusted to
2012 CDN dollars, declined due to decreased utilization
over the 5 years but the decline was not consistent at each
level of comorbidity. For those with 0 comorbid conditions
the costs stayed the same, for 1–2 comorbid conditions the
average per patient costs increased by about $200 over
time, whereas those with 3+ declined by $1600.
Discussion
This study makes an important contribution to our
understanding of health-system burden of communitydollars) by level of comorbidity and by service type
Fig. 4 Per patient health service use costs over 5 years (2008 to 2012) adjusted to 2012 CDN dollars for patients with 0, 1, 2, or 3 or more
comorbid conditions (CC)
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found that health service use increased substantially with
the number of comorbidities, with those with three or
more comorbid conditions seeing a GP and specialist
more than once a month on average. In a systematic re-
view by Lehnert et al. [38] the authors reported that al-
most all studies observed a positive association of multiple
chronic conditions and health service use and costs, and
that several studies found a near exponential relationship
between the number of chronic conditions and costs.
We also wanted to examine how the level of comorbidity
impacts both dementia-related and non-dementia-related
health service utilization, as one could make a case that ei-
ther one or both could increase as comorbidity increases.
We found that overall health service use and costs in-
creased with number of comorbidities, but this was
driven mostly by non-dementia-related use. In fact,
even in people with no other comorbidities, we found
that non-dementia-related use was greater than dementia-
related use. The dramatic increase in non-dementia re-
lated services may indicate that dementia is negatively
impacting self-care and management for other chronic
conditions. This could be exacerbated by the under-
diagnosis of chronic conditions in older adults [39] espe-
cially in those with dementia [40]. However, it may also be
partially explained by our data source. For example, for
hospitalizations we used the “most responsible diagnosis”,
which is based on the diagnosis considered to have most
contributed to the overall length of stay, to determine if a
hospital episode was dementia-related or non-dementia-
related. This could happen if dementia is accelerating
other chronic conditions (i.e., impacting non-dementia-
related health service use) or increases the likelihood of
other acute events, such as falls or pneumonia, the
hospitalization may not be directly attributed to dementia
or captured in the comorbid conditions that we counted.
The most common reasons for hospitalizations for peoplewith AD are syncope, falls and trauma, which would not
likely be counted as “dementia-related use” in these
analyses [3].
Hypertension and arthritis were the most common co-
morbidities in the dementia cohort. In a recent systematic
review of disease clusters in older adults, Sinnige et al [41]
found that hypertension and stroke were the most common
diseases to cluster with dementia, although they reported
that dementia was considered in only one-fifth of the stud-
ies included in the review. Our results are similar to the
most common combinations of chronic conditions found
in the general population [42]. In a systematic review of
patterns of comorbidity in primary care, Violen et al. [43]
reported that osteoarthritis and cardiovascular and/or
metabolic conditions was the most common combination
of chronic conditions. When comparing dementia patients
and non-dementia patients in primary care, Schubert et al.
[24] found that comorbidity profiles were similar in the two
groups, however Bynum et al. [26] did not.
We found that the drivers of costs differed in people
with no comorbidity compared to those with three or
more chronic conditions. In those with no comorbidity,
the biggest driver was homecare and in those with three
or more chronic conditions, the biggest driver was acute
care episodes. In a 3-year follow-up study, Rudolph et al.
[44] found that 66 % of persons with Alzheimer’s disease
were hospitalized at least once and 47 % were hospital-
ized two or more times. Furthermore, even after adjust-
ing for age, gender and other potential confounders,
Phelan et al. [6] found that dementia patients were more
likely to be hospitalized than non-dementia patients (rate
ratio 1.41; 95 % CI 1.23–1.61) especially for ambulatory
care-sensitive conditions for which proactive outpatient
care may prevent the need for hospital stay (rate ratio 1.78;
95 % CI 1.38–2.31). Similar results were reported by Feng
et al. [45] who found that community-living people with
dementia were more likely to have potentially preventable
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tentially avoidable, and an emergency department visit
that resulted in a hospitalization, than those without
dementia. Our results suggest that this phenomenon
occurs increasingly with the level of comorbidity.
The impact of comorbidity on utilization is a particu-
larly important issue for ALC days. The estimates of the
percent of ALC patients with dementia range between
25 % [46] to over 60 % [37]. The use of hospital beds for
ALC patients can contribute to a decrease in acute care
capacity, emergency department overcrowding, and pa-
tient flow inefficiencies throughout the entire health-
care system [47]. We found that overall in older adults
with dementia that the ALC LOS increased with level
of comorbidity, but this again was mostly driven by
non-dementia-related hospital stays. This suggests that
the impact of dementia on ALC days may be under-
estimated in administrative-data based studies and un-
derscores the complexity of these patients. Most ALC
patients are waiting for placement in long-term care fa-
cilities [37, 48]. A study exploring ALC patients waiting
for nursing home admission, however, found that some
of these patients could be discharged to a community
setting with the support of transitional programs and
increased community care [49]. As most people with
dementia want to stay at home for as long as possible
[50], this would require a greater integration of care be-
tween the acute and post-acute care providers [51].
Using comprehensive administrative data, this study
represents all community-living older adults in Ontario
with dementia. However, this study has limitations. We
follow a cohort over time, but have restricted the assess-
ment of comorbidity to the baseline. As we would not
be capturing new comorbidities over the 5 years, this
would tend to underestimate the impact of comorbidity
on utilization. For example, those with 0 comorbidities
at baseline could have three or more comorbidities by
year 5. As well, we included a restricted list of comor-
bidities to 14 conditions. This list does, however, include
the most common combinations of conditions identified
in Canada [42] as well the most common conditions in-
cluded in multi-morbidity research [52]. Although we
were able to present a snapshot of community living older
adults with dementia in our cohort, we lacked information
on their degree of cognitive impairment. The degree of
cognitive impairment is related to healthcare utilization
and costs [25] and impacts the ability to self-manage other
chronic conditions. We excluded medications from our
estimates of utilization and costs. Although medications
are an important aspect of healthcare expenditures in
older adults, research suggests they contribute a relatively
lower proportion of overall healthcare costs in people with
dementia. In a study of Medicare beneficiaries, those
with Alzheimer’s disease or dementia had higher averageannual per-person payments for all healthcare services
(hospital, physician and other medical providers, nursing
home, and home healthcare) except for prescription medi-
cations [3]. Because of our health-service perspective, we
did not include utilization or costs associated with in-
formal care which are significant in older adults with
dementia [3, 53]. Finally, our classification of health
service use into dementia-related and non-dementia-
related is based on the most responsible condition. In
cases where utilization was for the treatment of sequelae
of dementia (e.g., falls or delirium), it may not be counted
as dementia-related and thus underestimate dementia-
related use. We did, however, find a consistent trend over
all types of health service use and different administrative
data sources.
Conclusions
These data reflect the totality of publicly-funded health
services provided for a cohort of community-living older
adults with dementia in Ontario, the most populous
province of Canada. We found that the majority of
community-living older adults with dementia have mul-
tiple co-existing chronic conditions which are strongly
associated with increased healthcare service utilization
and costs. While increased utilization and associated costs
may not reflect actual need or optimal use [21], they
nevertheless reflect burden and suggest areas where op-
portunities exist to reduce burden. For example, homecare
services targeting prevention and health promotion could
reduce the use of expensive acute care services, particu-
larly those that are unplanned and/or potentially avoidable
[45]. In addition, older adults with dementia frequently
experience care transitions [5, 24], which require an in-
tegration of services to provide effective continuing care.
Our results suggest that policy makers should direct re-
sources to comprehensive programs that take a holistic
view to identify the needs of patients in the context of
other comorbidities and are tailored to the complexity of
care required for persons with dementia living in the
community [54].
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